Hb Bart's hydrops fetalis
MONDO:0015579Alpha thalassemia caused by variation in all four copies of the alpha hemoglobin genes (e.g., homozygous deletion encompassing HBA1 and HBA2).
Also known as: Alpha-thalassemia major, HBA1;HBA2 digenic quadallelic Hb Bart’s hydrops fetalis, Haemoglobin Bart's hydrops fetalis, Hb Bart’s hydrops fetalis caused by quadallelic variation in HBA1;HBA2, Hb Bart’s hydrops fetalis related to quadallelic variation in HBA1 and HBA2, Hemoglobin Bart's hydrops fetalis, alpha-thalassemia hydrops fetalis, homozygous alpha0-thalassemia
19 clinical trials for this condition and its sub-types, 3 tagged with Hb Bart's hydrops fetalis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New pill may cut transfusions for thalassemia patients
Disease control OngoingThis phase 3 study tests whether mitapivat, an oral medication, can safely reduce the number of blood transfusions needed by adults with transfusion-dependent alpha- or beta-thalassemia. Participants receive either mitapivat or a placebo for 48 weeks. The main goal is to see if m…
Phase 3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a simple exercise routine strengthen bones in thalassemia?
Disease control OngoingThis trial investigates whether a 12- to 36-week program of aerobic and strength exercises can improve body composition, muscle function, and bone density in adolescents and adults with thalassemia. Participants will follow a self-directed routine of 30 minutes of exercise, 5 day…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC